PMID- 26928175
OWN - NLM
STAT- MEDLINE
DCOM- 20170208
LR  - 20221207
IS  - 1421-9794 (Electronic)
IS  - 0009-3157 (Linking)
VI  - 61
IP  - 5
DP  - 2016
TI  - Gemcitabine-Induced Subacute Cutaneous Lupus Erythematosus: A Case Report.
PG  - 236-9
LID - 10.1159/000443762 [doi]
AB  - Subacute cutaneous lupus erythematosus (SCLE) is a rare eruption related to 
      several pharmacological and chemotherapy agents. We present a 63-year-old female 
      with recurrent epithelial ovarian cancer who developed SCLE after administration 
      of gemcitabine. Following discontinuation of gemcitabine and after oral steroid 
      treatment, all skin lesions disappeared. In view of the extensive use of 
      gemcitabine in recurrent ovarian cancer, it is important to be aware of the 
      possibility of SCLE occurrence in these patients.
CI  - (c) 2016 S. Karger AG, Basel.
FAU - Ben Zvi, Masha
AU  - Ben Zvi M
FAU - Vaknine, Hananya
AU  - Vaknine H
FAU - Menczer, Joseph
AU  - Menczer J
FAU - Peled, Ofri
AU  - Peled O
FAU - Ben Shem, Erez
AU  - Ben Shem E
FAU - Schreiber, Letizia
AU  - Schreiber L
FAU - Levy, Tally
AU  - Levy T
LA  - eng
PT  - Case Reports
PT  - Journal Article
DEP - 20160301
PL  - Switzerland
TA  - Chemotherapy
JT  - Chemotherapy
JID - 0144731
RN  - 0 (Anti-Inflammatory Agents)
RN  - 0 (Antimetabolites, Antineoplastic)
RN  - 0W860991D6 (Deoxycytidine)
RN  - VB0R961HZT (Prednisone)
RN  - 0 (Gemcitabine)
SB  - IM
MH  - Administration, Oral
MH  - Anti-Inflammatory Agents/therapeutic use
MH  - Antimetabolites, Antineoplastic/*adverse effects/therapeutic use
MH  - Deoxycytidine/adverse effects/*analogs & derivatives/therapeutic use
MH  - Female
MH  - Humans
MH  - Lupus Erythematosus, Cutaneous/drug therapy/*etiology
MH  - Lymph Nodes/metabolism
MH  - Middle Aged
MH  - Neoplasm Recurrence, Local
MH  - Ovarian Neoplasms/drug therapy/surgery
MH  - Positron Emission Tomography Computed Tomography
MH  - Prednisone/therapeutic use
MH  - Skin/metabolism/pathology
MH  - Treatment Outcome
MH  - Gemcitabine
EDAT- 2016/03/02 06:00
MHDA- 2017/02/09 06:00
CRDT- 2016/03/02 06:00
PHST- 2015/08/27 00:00 [received]
PHST- 2016/01/04 00:00 [accepted]
PHST- 2016/03/02 06:00 [entrez]
PHST- 2016/03/02 06:00 [pubmed]
PHST- 2017/02/09 06:00 [medline]
AID - 000443762 [pii]
AID - 10.1159/000443762 [doi]
PST - ppublish
SO  - Chemotherapy. 2016;61(5):236-9. doi: 10.1159/000443762. Epub 2016 Mar 1.